These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 2718445

  • 1. [The fibrinogen-fibrin-fibrinolysis system in rheumatoid arthritis].
    Belitskaia GA, Palienko IA, Shevchenko LI, Fedorova NE.
    Vrach Delo; 1989 Jan; (1):47-50. PubMed ID: 2718445
    [Abstract] [Full Text] [Related]

  • 2. [Indices of the blood fibrinolytic system in osteoarthrosis and rheumatoid arthritis].
    Palienko IA, Nikula TD, Belitskaia GA, Shevchenko LI, Fedorova NE.
    Vrach Delo; 1989 Apr; (4):57-60. PubMed ID: 2756690
    [Abstract] [Full Text] [Related]

  • 3. [Selected indicators of blood coagulation and fibrinolysis in articular exudates of patients with rheumatoid arthritis].
    Dmoszyńska-Giannopoulou A, Kowalewski J, Pytko H, Szczepański L.
    Reumatologia; 1979 Apr; 17(2):157-60. PubMed ID: 472525
    [No Abstract] [Full Text] [Related]

  • 4. [Fibrinolytic activity of the blood and synovial fluid in patients with rheumatoid arthritis].
    Erov NK.
    Ter Arkh; 1986 Apr; 58(7):73-7. PubMed ID: 2945279
    [Abstract] [Full Text] [Related]

  • 5. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
    Carmassi F, De Negri F, Morale M, Puccetti R, Chung SI.
    Int J Tissue React; 1994 Apr; 16(2):89-93. PubMed ID: 7960505
    [Abstract] [Full Text] [Related]

  • 6. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J, Niewiarowski S, Gurewich V, Thomas DP.
    J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
    [No Abstract] [Full Text] [Related]

  • 7. [Studies on plasma F. XIII subunit a level and the detection of soluble fibrin monomer in collagen diseases].
    Okubo S, Suzuki H, Ishida T, Yasunaga K.
    Rinsho Ketsueki; 1986 Aug; 27(8):1339-44. PubMed ID: 3795511
    [No Abstract] [Full Text] [Related]

  • 8. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C.
    Scand J Clin Lab Invest Suppl; 1983 Aug; 166():1-60. PubMed ID: 6226084
    [No Abstract] [Full Text] [Related]

  • 9. [Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].
    Panchenko VM, Salakhidinov Z, Khaĭkina MB.
    Probl Endokrinol (Mosk); 1979 Aug; 25(1):11-5. PubMed ID: 581702
    [Abstract] [Full Text] [Related]

  • 10. [An analysis of a disorder in the fibrin-forming phase in virtually healthy middle-aged and elderly subjects by using the ancistron test].
    Platonova TN, Sushko OO, Lukinova NI, Solovĭov DA.
    Fiziol Zh (1994); 1994 Aug; 40(3-4):63-70. PubMed ID: 7621957
    [Abstract] [Full Text] [Related]

  • 11. [A comparative evaluation of methods for determining the activity of rheumatic diseases].
    Belitskaia GA, Nikula TD, Palienko IA, Shevchenko LI, Fedorova NE.
    Vrach Delo; 1989 Aug; (8):25-7. PubMed ID: 2588517
    [Abstract] [Full Text] [Related]

  • 12. [Blood coagulation, fibrinolysis and various values of Lansbury's activity index in rheumatoid arthritis patients].
    Motohashi Y, Nakazawa T.
    Arerugi; 1992 Feb; 41(2 Pt 1):148-55. PubMed ID: 1567284
    [Abstract] [Full Text] [Related]

  • 13. [Diagnostic value of clinico-biological indices in infectious nonspecific polyarthritis].
    Vishnevskaya IT, Balaban SIa.
    Sov Med; 1971 Nov; 34(11):77-82. PubMed ID: 5160642
    [No Abstract] [Full Text] [Related]

  • 14. [System of coagulation and fibrinolysis in rheumatoid arthritis. II. Factors of coagulation and fibrinolysis in patients serum. 3. Factors of coagulation and fibrinolysis in the plasma of patients].
    Stachurska J, Szpilman H, Pazdur J.
    Reumatologia; 1966 Nov; 4(3):221-6 contd. PubMed ID: 5954625
    [No Abstract] [Full Text] [Related]

  • 15. [Soluble fibrin monomer complexes in thromboembolism].
    Gryglik J.
    Przegl Lek; 1982 Sep; 39(8):551-3. PubMed ID: 6753042
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test)].
    Vorlová Z, Dyr IE.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979 Sep; 106(5-6):967-70. PubMed ID: 94893
    [No Abstract] [Full Text] [Related]

  • 17. [Content of fibrinogen degradation products, soluble fibrin and the fibrinolytic activity of blood in myocardial infarct].
    Belousov IuB, Panchenko EP, Pivovarov VA, Nemiro VK.
    Kardiologiia; 1979 Aug; 19(8):87-91. PubMed ID: 491364
    [Abstract] [Full Text] [Related]

  • 18. [The levels of FDP, FDP-E and D-dimer in patients with rheumatoid arthritis].
    Nakashima M, Aoyagi T, Aratake K, Kawabe Y, Eguchi K.
    Ryumachi; 1998 Dec; 38(6):793-800. PubMed ID: 10047717
    [Abstract] [Full Text] [Related]

  • 19. [The action of regulator peptides with different biological activities on the process of fibrin-monomer polymerization and on nonenzymatic fibrinolysis].
    Ashmarin IP, Liapina LA, Pastorova VE, Kudriashov BA.
    Patol Fiziol Eksp Ter; 1991 Dec; (4):3-5. PubMed ID: 1798648
    [Abstract] [Full Text] [Related]

  • 20. Activation of plasma coagulation by retransfusion of unwashed drainage blood after hip joint arthroplasty: a prospective study.
    Duchow J, Ames M, Hess T, Seyfert U.
    J Arthroplasty; 2001 Oct; 16(7):844-9. PubMed ID: 11607899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.